title: Femoral head osteonecrosis after topical corticosteroid therapy.
authors.forename: A
authors.initials: A
authors.lastname: el Maghraoui
authors.forename: F
authors.initials: F
authors.lastname: Tabache
authors.forename: A
authors.initials: A
authors.lastname: Bezza
authors.forename: D
authors.initials: D
authors.lastname: Ghafir
authors.forename: V
authors.initials: V
authors.lastname: Ohayon
authors.forename: M I
authors.initials: MI
authors.lastname: Archane
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001623:Betamethasone / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D005271:Femur Head Necrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D011859:Radiography
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone